journal article·2020-06

Construction of carrier-free porphyrin-based drug self-framed delivery system to reverse multidrug resistance through photodynamic-chemotherapy

Lin Liu, Yanli Bao, Jinze Wang, Chunsheng Xiao, Li Chen

Dyes and Pigments· Volume 177
Publisher page

Abstract

Abstract For clinical application, it is still giant challenge to reverse multidrug resistance. High efficiency, low toxicity and simplicity are key issues to design nanomedicines. Herein, we fabricated porphyrin-based drug self-framed delivery systems without any carrier via simple method, in which water-soluble photosensitizer (tetra sodium meso-tetra (sulfonatophenyl)-porphyrin, H2TPPS) and chemotherapeutic drug (doxorubicin, DOX) could self-assemble to form H2TPPS@DOX nanoparticles by supramolecular interaction such as hydrophobic, electrostatic and π-π stacking interactions. H2TPPS@DOX exhibited higher drug capacity of 42.4% and a relatively uniform size of average 90 nm, being demonstrated to maintain high-stable during blood circulation. Under light irradiation, H2TPPS@DOX could effectively generate singlet oxygen to obviously block DOX efflux and ultimately induce apoptosis to effectively reverse multidrug resistance of tumor cells. Moreover, the combination of photosensitizer and anticancer drug could enhance therapeutic effect, outlining a novel strategy to prepare synergistic drug delivery system to overcome multidrug resistance and improve treatment effect.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Luminescence and Fluorescent Materials · Advanced biosensing and bioanalysis techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (25)

Show source-provided references
1. Design, synthesis and evaluation of a novel series of inhibitors reversing P‐glycoprotein mediated multidrug resistance10.1111/cbdd.13338 ↗
2. Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting P-glycoprotein10.1177/107327480301000207 ↗
3. Synthesis and biological evaluation of 2,5-disubstituted furan derivatives as P-glycoprotein inhibitors for Doxorubicin resistance in MCF-7/ADR cell10.1016/j.ejmech.2018.04.012 ↗
4. Combination of small molecule prodrug and nanodrug delivery: amphiphilic drug-drug conjugate for cancer therapy10.1021/ja505212y ↗
5. Nanoscale coordination polymers codeliver chemotherapeutics and siRNAs to eradicate tumors of cisplatin-resistant ovarian cancer10.1021/jacs.6b02486 ↗
6. Ectopic expression of poplar ABC transporter PtoABCG36 confers Cd tolerance in Arabidopsis thaliana10.3390/ijms20133293 ↗
7. Nonionic surfactants modulate the transport activity of ATP-binding cassette (ABC) transporters and solute carriers (SLC): relevance to oral drug absorption10.1016/j.ijpharm.2019.05.033 ↗
8. Single nanoparticle plasmonic spectroscopy for study of charge-dependent efflux function of multidrug ABC transporters of single live Bacillus subtilis cells10.1021/acs.jpcc.6b03313 ↗
9. Doxorubicin-tethered responsive gold nanoparticles facilitate intracellular drug delivery for overcoming multidrug resistance in cancer cells10.1021/nn200007z ↗
10. Doxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by inhibiting P-glycoprotein and depleting ATP10.1158/0008-5472.CAN-08-2747 ↗
11. P-glycoprotein antibody functionalized carbon nanotube overcomes the multidrug resistance of human leukemia cells10.1021/nn9011225 ↗
12. Reactive oxygen species (ROS)-Based nanomedicine10.1021/acs.chemrev.8b00626 ↗
13. A new NIR-triggered doxorubicin and photosensitizer indocyanine green co-delivery system for enhanced multidrug resistant cancer treatment through simultaneous chemo/photothermal/photodynamic therapy10.1016/j.actbio.2017.06.026 ↗
14. Mitochondria-targeted chimeric peptide for trinitarian overcoming of drug resistance10.1021/acsami.6b06522 ↗
15. Stimuli-responsive nanomedicines for overcoming cancer multidrug resistance10.7150/thno.22679 ↗
16. Targeted production of reactive oxygen species in mitochondria to overcome cancer drug resistance10.1038/s41467-018-02915-8 ↗
17. An imaging-guided platform for synergistic photodynamic/photothermal/chemo-therapy with pH/temperature-responsive drug release10.1016/j.biomaterials.2015.05.016 ↗
18. Graphene oxide covalently grafted upconversion nanoparticles for combined NIR mediated imaging and photothermal/photodynamic cancer therapy10.1016/j.biomaterials.2013.06.045 ↗
19. Synthesis of self-assembled porphyrin nanoparticle photosensitizers10.1021/acsnano.8b01010 ↗
20. Self-assembled oxaliplatin(IV) prodrug–porphyrin conjugate for combinational photodynamic therapy and chemotherapy10.1021/acsami.9b04557 ↗
21. A self-assembling nanomedicine of conjugated linoleic acid-paclitaxel conjugate (CLA-PTX) with higher drug loading and carrier-free characteristic10.1038/srep36614 ↗
22. Carrier-free immobilized enzymes for biocatalysis10.1007/s10529-009-0173-4 ↗
23. Self-assembly nanostructure controlled sustained release, activity and stability of peptide drugs10.1016/j.ijpharm.2017.06.051 ↗
24. Porphyrin‐hyperbranched copolymer films as recyclable photooxidation catalysts for 1,5‐dihydroxynaphthalene10.1002/cctc.201701219 ↗
25. Hyperbranched phosphorescent conjugated polymer dots with iridium(III) complex as the core for hypoxia imaging and photodynamic therapy10.1021/acsami.7b09721 ↗